Neogenomics NEO
NASDAQ NEO
$19.17 -0.24 (-1.24%)
As of: Sep 22, 2026 · 10:49 AM EDT

Neogenomics (NEO) Convertible Debt (2020 - 2026)

Neogenomics' (NEO) quarterly Convertible Debt came in at $374.2 million in Q2 2026, up 9.72% on a YoY basis from $341.1 million in Q2 2025, and up 9.35% quarter-over-quarter from $342.2 million in Q1 2026.

Analysis

Neogenomics (NEO) Convertible Debt (2020 - 2026) Analysis & Trends

Neogenomics (NEO) has reported Convertible Debt for 7 consecutive years, with $374.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Convertible Debt rose 9.72% year-over-year to $374.2 million; the trailing twelve-month figure through Jun 2026 stood at $374.2 million (up 9.72% YoY), and the FY2025 full-year result was $341.9 million, changed 0.45% from the prior year.
  • Convertible Debt grew to $374.2 million in Q2 2026 per NEO's latest filing, from $342.2 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $538.9 million in Q1 2024 and bottomed at $339.6 million in Q2 2024.
  • Historically, Convertible Debt has averaged $440.3 million across 5 years, with a median of $453.7 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Convertible Debt sank 36.78% in 2025, then grew 9.72% in 2026.
  • Over 5 years, Convertible Debt stood at $535.3 million in 2022, then rose by 0.54% to $538.2 million in 2023, then tumbled by 36.76% to $340.3 million in 2024, then climbed by 0.45% to $341.9 million in 2025, then grew by 9.47% to $374.2 million in 2026.
  • According to Business Quant data, Convertible Debt over the past three periods registered $374.2 million, $342.2 million, and $341.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Neogenomics 2.55 Bn 2.40 Bn 91.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 374.24 Mn
Mar 31, 2026 342.24 Mn
Dec 31, 2025 341.86 Mn
Sep 30, 2025 341.48 Mn
Jun 30, 2025 341.10 Mn
Mar 31, 2025 340.71 Mn
Dec 31, 2024 340.34 Mn
Sep 30, 2024 339.96 Mn
Jun 30, 2024 339.58 Mn
Mar 31, 2024 538.92 Mn
Dec 31, 2023 538.20 Mn
Sep 30, 2023 537.48 Mn
Jun 30, 2023 536.76 Mn
Mar 31, 2023 536.04 Mn
Dec 31, 2022 535.32 Mn
Sep 30, 2022 534.61 Mn
Jun 30, 2022 533.90 Mn
Mar 31, 2022 533.19 Mn
Dec 31, 2021 532.48 Mn
Sep 30, 2021 531.78 Mn
API Access

Neogenomics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=NEO&period=max&api_key=YOUR_API_KEY